Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

43.16
Delayed Data
As of Jan 23
 -0.34 / -0.78%
Today’s Change
41.34
Today|||52-Week Range
54.73
-4.68%
Year-to-Date
No recent news for Dr.Reddy's Laboratories Ltd.

Today’s Trading

Previous close43.50
Today’s open43.21
Day’s range42.85 - 43.60
Volume551,341
Average volume (3 months)279,317
Market cap$7.4B
Dividend yield0.69%
Data as of 4:02pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)-15.85%
Earnings growth (this year)--
Earnings growth (next 5 years)+36.08%
Revenue growth (last year)-2.51%
P/E ratio0.7
Price/Sales3.28
Price/Book3.83

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-2.45-1.98%
TSROTESARO Inc-0.91-0.62%
SGENSeattle Genetics Inc-0.27-0.46%
UTHRUnited Therapeutics ...+0.40+0.26%
Data as of 4:14pm ET, 01/23/2017

Financials

Next reporting dateFebruary 4, 2017
EPS forecast (this quarter)$0.34
Annual revenue (last year)$2.4B
Annual profit (last year)$305.0M
Net profit margin12.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-IT
Saumen Chakraborty
Corporate headquarters
Hyderabad, Telangana

Forecasts


Search for Jobs